233 related articles for article (PubMed ID: 2642919)
1. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome.
Dunaif A; Graf M
J Clin Invest; 1989 Jan; 83(1):23-9. PubMed ID: 2642919
[TBL] [Abstract][Full Text] [Related]
2. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
[TBL] [Abstract][Full Text] [Related]
3. The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome.
Judd HL; Rigg LA; Anderson DC; Yen SS
J Clin Endocrinol Metab; 1976 Aug; 43(2):347-55. PubMed ID: 950366
[TBL] [Abstract][Full Text] [Related]
4. Do androgens directly regulate gonadotropin secretion in the polycystic ovary syndrome?
Dunaif A
J Clin Endocrinol Metab; 1986 Jul; 63(1):215-21. PubMed ID: 3086357
[TBL] [Abstract][Full Text] [Related]
5. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.
Dunaif A; Graf M; Mandeli J; Laumas V; Dobrjansky A
J Clin Endocrinol Metab; 1987 Sep; 65(3):499-507. PubMed ID: 3305551
[TBL] [Abstract][Full Text] [Related]
6. Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome.
Nestler JE; Barlascini CO; Matt DW; Steingold KA; Plymate SR; Clore JN; Blackard WG
J Clin Endocrinol Metab; 1989 Jun; 68(6):1027-32. PubMed ID: 2498378
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between hormonal and metabolic profiles in women with polycystic ovary syndrome].
Esposito V; Federico P; Lo Iudice G; Rispoli C; Sabatino P; D'Alessandro B
Minerva Endocrinol; 1992; 17(1):21-9. PubMed ID: 1495451
[TBL] [Abstract][Full Text] [Related]
8. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
9. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
[TBL] [Abstract][Full Text] [Related]
10. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.
Dunaif A; Segal KR; Futterweit W; Dobrjansky A
Diabetes; 1989 Sep; 38(9):1165-74. PubMed ID: 2670645
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
[TBL] [Abstract][Full Text] [Related]
12. Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome.
Dunaif A; Green G; Futterweit W; Dobrjansky A
J Clin Endocrinol Metab; 1990 Mar; 70(3):699-704. PubMed ID: 2106527
[TBL] [Abstract][Full Text] [Related]
13. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome.
Nestler JE; Powers LP; Matt DW; Steingold KA; Plymate SR; Rittmaster RS; Clore JN; Blackard WG
J Clin Endocrinol Metab; 1991 Jan; 72(1):83-9. PubMed ID: 1898744
[TBL] [Abstract][Full Text] [Related]
14. Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO.
Lobo RA; Granger L; Goebelsmann U; Mishell DR
J Clin Endocrinol Metab; 1981 Jan; 52(1):156-8. PubMed ID: 6778890
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone and somatomedin-C secretion in patients with polycystic ovarian disease. Their relationships with hyperinsulinism and hyperandrogenism.
Lanzone A; Fulghesu AM; Pappalardo S; Proto C; Le Donne M; Andreani CL; Muscatello R; Caruso A; Mancuso S
Gynecol Obstet Invest; 1990; 29(2):149-53. PubMed ID: 2110544
[TBL] [Abstract][Full Text] [Related]
16. Hyperinsulinemia amplifies GnRH agonist stimulated ovarian steroid secretion in women with polycystic ovary syndrome.
Tosi F; Negri C; Perrone F; Dorizzi R; Castello R; Bonora E; Moghetti P
J Clin Endocrinol Metab; 2012 May; 97(5):1712-9. PubMed ID: 22419715
[TBL] [Abstract][Full Text] [Related]
17. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
Apter D; Bützow T; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
[TBL] [Abstract][Full Text] [Related]
18. Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist.
Lanzone A; Fulghesu AM; Andreani CL; Apa R; Fortini A; Caruso A; Mancuso S
Hum Reprod; 1990 Feb; 5(2):143-9. PubMed ID: 2108986
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
[TBL] [Abstract][Full Text] [Related]
20. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
Rittmaster RS; Thompson DL
J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
